Comparison of Placebo and Aspirin in Patients with Magnetically Levitated Left Ventricular Assist Device

Patients with a fully magnetically levitated left ventricular assist device were followed up for 12 months in a randomized trial comparing placebo to aspirin with a vitamin K antagonist. The primary end point was evaluated at 12 months, and patients who continued receiving the treatment group medication were eligible for continued follow-up.

The probability of death or major hemocompatibility-related adverse event was lower in the placebo group compared to the aspirin group at both 12 and 24 months

Source: Healthcare Press (healthcarepress.net)

Placebo Aspirin Vitamin K Antagonist Left Ventricular Assist Device Randomized Trial Primary End Point Follow-Up Hemocompatibility

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study on the Effectiveness of Percutaneous Coronary Intervention in Patients with Stable AnginaA double-blind, randomized, placebo-controlled trial was conducted to determine whether percutaneous coronary intervention (PCI) relieves angina more than a placebo procedure in patients with stable angina who are not receiving antianginal medication. The study followed patients for 12 weeks and assessed the angina symptom score as the primary endpoint.
Source: medical_xpress - 🏆 101. / 51 Read more »

Willow bark may be the source of a new antiviral drugScientists have found that specially processed samples of willow bark extract have an antiviral effect which isn’t seen in already known medical compounds from willow bark, such as salicylic acid, the precursor to modern aspirin.
Source: NewsMedical - 🏆 19. / 71 Read more »

ELN leader tries to justify why group kidnapped parents of Luis DiazLiverpool star Luis Diaz's father was rescued on November 9 after being kidnapped and held hostage by the ELN for 12 days
Source: EchoWhatsOn - 🏆 74. / 59 Read more »

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetesFindings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes.
Source: NewsMedical - 🏆 19. / 71 Read more »

Man appears in court charged with murder after 'disturbance' four years agoA trial date has been set
Source: MENnewsdesk - 🏆 23. / 69 Read more »

Glasgow group break stigma surrounding yoga and bring it to the working classThe not-for-profit organisation, started by Mick Gallagher and Caroline Smart, teaches both mat-based and chair yoga in community centres located across Glasgow.
Source: Glasgow_Live - 🏆 4. / 97 Read more »